These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 12653259)
21. The Role of Smoking as a Modifiable Risk Factor in Diabetic Nephropathy. Jose MJ; Varkey V; Chandni R; Zubaida PA; Maliekkal J J Assoc Physicians India; 2016 Jul; 64(7):34-38. PubMed ID: 27759340 [TBL] [Abstract][Full Text] [Related]
22. Association of reduced red blood cell deformability and diabetic nephropathy. Brown CD; Ghali HS; Zhao Z; Thomas LL; Friedman EA Kidney Int; 2005 Jan; 67(1):295-300. PubMed ID: 15610255 [TBL] [Abstract][Full Text] [Related]
23. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051 [TBL] [Abstract][Full Text] [Related]
24. Non-autoimmune primary hypothyroidism in diabetic and non-diabetic chronic renal dysfunction. Bando Y; Ushiogi Y; Okafuji K; Toya D; Tanaka N; Miura S Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):408-15. PubMed ID: 12518252 [TBL] [Abstract][Full Text] [Related]
25. Risk factors for progression of renal disease in patient with diabetic nephropathy. Unsal A; Koc Y; Basturk T; Akgun AO; Sakaci T; Ahbap E Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):878-83. PubMed ID: 22953635 [TBL] [Abstract][Full Text] [Related]
26. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database. Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245 [TBL] [Abstract][Full Text] [Related]
27. The Saudi Diabetic Kidney Disease study (Saudi-DKD): clinical characteristics and biochemical parameters. Al-Rubeaan K; Siddiqui K; Alghonaim M; Youssef AM; AlNaqeb D Ann Saudi Med; 2018; 38(1):46-56. PubMed ID: 29295969 [TBL] [Abstract][Full Text] [Related]
28. Progression of diabetic nephropathy: value of intrarenal resistive index (RI). Milovanceva-Popovska M; Dzikova S Prilozi; 2007 Jul; 28(1):69-79. PubMed ID: 17921919 [TBL] [Abstract][Full Text] [Related]
29. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy. Sanaka T; Akizawa T; Koide K; Koshikawa S Ther Apher Dial; 2004 Jun; 8(3):232-40. PubMed ID: 15154877 [TBL] [Abstract][Full Text] [Related]
30. Treatment of diabetic nephropathy with angiotensin II receptor antagonist. Lewis EJ; Lewis JB Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737 [TBL] [Abstract][Full Text] [Related]
31. Longitudinal prospective observational type study about determinants of renal resistive index variations in chronic renal failure patients treated with conventional medical and dietetic therapy. Brardi S; Cevenini G; Giovannelli V; Romano G Arch Ital Urol Androl; 2017 Dec; 89(4):305-309. PubMed ID: 29473380 [TBL] [Abstract][Full Text] [Related]
32. Renal outcomes in patients with type 2 diabetes with or without coexisting non-diabetic renal disease. Chang TI; Park JT; Kim JK; Kim SJ; Oh HJ; Yoo DE; Han SH; Yoo TH; Kang SW Diabetes Res Clin Pract; 2011 May; 92(2):198-204. PubMed ID: 21320734 [TBL] [Abstract][Full Text] [Related]
33. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients. Wirta OR; Pasternack AI; Mustonen JT; Koivula TA; Harmoinen A Nephrol Dial Transplant; 1996 Mar; 11(3):449-56. PubMed ID: 8671814 [TBL] [Abstract][Full Text] [Related]
34. Nephrotic range proteinuria as a strong risk factor for rapid renal function decline during pre-dialysis phase in type 2 diabetic patients with severely impaired renal function. Kitai Y; Doi Y; Osaki K; Sugioka S; Koshikawa M; Sugawara A Clin Exp Nephrol; 2015 Dec; 19(6):1037-43. PubMed ID: 25680889 [TBL] [Abstract][Full Text] [Related]
35. High urinary sulfate concentration is associated with reduced risk of renal disease progression in type 2 diabetes. van den Born JC; Frenay AR; Bakker SJ; Pasch A; Hillebrands JL; Lambers Heerspink HJ; van Goor H Nitric Oxide; 2016 May; 55-56():18-24. PubMed ID: 26952289 [TBL] [Abstract][Full Text] [Related]
36. Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes. Andrésdóttir G; Bakker SJ; Hansen HP; Parving HH; Rossing P Diabet Med; 2013 May; 30(5):563-6. PubMed ID: 23324103 [TBL] [Abstract][Full Text] [Related]
37. [Prospective follow-up study of renal function in type 2 diabetes]. Hadjadj S; Fanelli A; Torremocha F; Maréchaud R Arch Mal Coeur Vaiss; 2001 Aug; 94(8):928-32. PubMed ID: 11575233 [TBL] [Abstract][Full Text] [Related]
38. [Role of intrarenal product TNF-alpha in the development of glomerular and tubulointerstitial tissues changes in elderly patients with diabetic nephropathy]. Rakitianskaia IA; Riabov SI; Azanchevskaia SV; Riabova TS; Al-Barbari K; Gurkov AS; Popova VB Adv Gerontol; 2013; 26(4):658-65. PubMed ID: 24738256 [TBL] [Abstract][Full Text] [Related]
39. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease. Fragoso A; Mendes F; Silva AP; Neves PL J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409 [TBL] [Abstract][Full Text] [Related]
40. [Intrarenal resistive index (RI) from renal duplex Doppler sonography in type II diabetic patients with nephropathy]. Hosojima H Nihon Rinsho; 2002 Aug; 60 Suppl 8():676-81. PubMed ID: 12355832 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]